Efficacy and/or Effectiveness of Compound of Gabapentin, Ketamine, Lidocaine and Tramadol as Treatment for Musculoskeletal Pain
|
|
- Jewel Delphia Clarke
- 6 years ago
- Views:
Transcription
1 Evidence-Based Practice Group Answers to Clinical Questions Efficacy and/or Effectiveness of Compound of Gabapentin, Ketamine, Lidocaine and Tramadol as Treatment for Musculoskeletal Pain A Rapid Systematic Review By WorkSafeBC Evidence-Based Practice Group Dr. Craig Martin Manager, Clinical Services Chair, Evidence-Based Practice Group March 2017 Clinical Services Worker and Employer Services
2 Musculoskeletal Pain i About this report Efficacy and/or Effectiveness of Compound of Gabapentin, Ketamine, Lidocaine and Tramadol as Treatment for Musculoskeletal Pain Published: March 2017 About the Evidence-Based Practice Group The Evidence-Based Practice Group was established to address the many medical and policy issues that WorkSafeBC officers deal with on a regular basis. Members apply established techniques of critical appraisal and evidence-based review of topics solicited from both WorkSafeBC staff and other interested parties such as surgeons, medical specialists, and rehabilitation providers. Suggested Citation WorkSafeBC Evidence-Based Practice Group, Martin CW. Efficacy and/or Effectiveness of Compound of Gabapentin, Ketamine, Lidocaine and Tramadol as Treatment for Musculoskeletal Pain. Richmond, BC: WorksafeBC Evidence-Based Practice Group; March Contact Information Evidence-Based Practice Group WorkSafeBC PO Box 5350 Stn Terminal Vancouver BC V6B 5L5 craig.martin@worksafebc.com Phone Toll-free ext 7417
3 Musculoskeletal Pain 1 Objective To determine whether there is any evidence to support the efficacy and/or effectiveness of a compound comprising of 5% gabapentin, 5% ketamine, 2.5 g lidocaine and 2.5 g tramadol in treating musculoskeletal pain, especially for muscle sprain/strain and contusion? Methods A comprehensive literature search was conducted on March 29, The search was done on commercial medical literature databases, including the Cochrane Database of Systematic Reviews (2005 to March 22, 2017), ACP Journal Club (1991 to March 2017), Database of Abstracts of Reviews of Effects (1st Quarter 2016), Cochrane Central Register of Controlled Trials (February 2017), UK NHS Health Technology Assessment (4th Quarter 2016), UK NHS Economic Evaluation Database (1st Quarter 2016), BIOSIS Previews (1969 to 2008), Embase (1974 to 2017 March 28), MEDLINE Epub Ahead of Print, Medline In-Process & Other Non-Indexed Citations, MEDLINE Daily Update and MEDLINE (1946 to Present), that are available through Ovid platform. The searches were conducted by employing combinations of keywords, consisting of: 1. (((gabapentin 5%) OR (gabapentin 2.5 g)) AND ((ketamine 5%) OR (ketamine 2.5 g)) AND (lidocaine 2.5 g) AND (tramadol 2.5 g)) No published studies were identified from this search. 2. (gabapentin AND ketamine AND lidocaine AND tramadol) AND (topical OR compound) Twenty-four (1-24) published studies were identified through this search. One (17) study out of the 24 identified was thought to be relevant and was retrieved in full for further appraisal. However, this article did not provide any data/information on the efficacy/effectiveness of topical or compound analgesics in general, or gabapentinketamine-lidocaine-tramadol compound in particular. 3. (topical tramadol)
4 Musculoskeletal Pain 2 The keywords topical tramadol were specifically searched since there was a concern with the fact that an opioid is part of this particular compound Seven (25-31) published studies were identified through this search. Five (25,27,29-31) published studies were identified from the above seven studies as investigating the efficacy/effectiveness of topical tramadol. However, upon examination of the titles and abstracts of these five (25,27,29-31) studies, none of these studies were relevant to the objective of this systematic review as all five studies were conducted among children, to treat acute post-operative pain of post-tonsillectomy or tooth extraction. No limitations, such as on the language or date of publication, were employed in this search. Published studies in the possession of the Evidence-Based Practice Group from previous systematic reviews on topical analgesics, as well as resulting from the Group s daily literature surveillance were also searched. Six (32-37) further studies were retrieved from this collection and presented below. Manual searches were also conducted on the references of the fully retrieved articles. No further study was identified through this search. Results This systematic review failed to identify any published study investigating the efficacy/effectiveness of a gabapentin, ketamine, lidocaine and tramadol compound, in any concentration/composition. In the last five years, the United States has seen a nearly five-fold increase in the number of compounded drugs available via prescription (32). Such topical compounds are advertised as featuring numerous beneficial effects, including: o The notion that with topical drugs, patients will theoretically avoid systemic absorption and may thus also avoid subsequent side effects o The combining of multiple agents into a single preparation reduces the number of tablets or capsules needed and thus reduces the difficulty experienced by patients who have trouble swallowing oral preparations o The process of compounding drugs can omit ingredients that cause allergic or other adverse reaction(s) in the patient However, in general, evidence on the efficacy/effectiveness, either pertaining to each individual compound ingredient or pertaining to the
5 Musculoskeletal Pain 3 compounds itself, are lacking (32) ; additionally, quality control regarding the process of compounding are questionable and potential adverse events cannot be discounted (36,37). Compound drugs are not US FDA or Health Canada approved; as such quality and safety standards in the manufacturing of this compound can be an issue. The Ohio State Board of Pharmacy minutes reveal that when quality tests were performed on some compounded products, the potency of the tested drugs reflected a sizeable difference (ranging from approximately 27% to 85%) from the stated/listed amounts of active ingredients as found on the products labels. Also in Ohio, the testing for sterility, fungi, or endotoxins conducted on some compound samples (prior to dispensing to customers) showed fungal contamination likely were present in the compound drugs already dispensed/distributed to patients. To date, the transdermal absorption of drugs and its subsequent deep tissue delivery, a complex process with many factors potentially influencing the penetration mechanism, is not yet fully understood (34-36). As such, evidence on the efficacy/effectiveness of such topical compound medication is urgently needed prior to its application. o The stratum corneum of the skin is considered to be the greatest barrier to drug absorption, and the science of dermal absorption, penetration, and distribution remains an area of study under further development. o Drug absorption into and through the skin into muscle depends on the physical and chemical characteristics of the drug. These include molecular size, lipophilicity, permeability, and fraction unbound in viable skin. Additionally, the concentration of the drug, duration of contact, and use of an occlusive barrier over a topical agent can all alter drug absorption and penetration. o Once a drug is absorbed into the skin, transdermal penetration into underlying tissue is needed for joint or muscle pain to be relieved. It is believed that the most important factor for flux and drug distribution is the molecular size of the drug. Other important drug characteristics are: o A more lipid soluble drug is expected to have a greater depth of penetration o A higher fraction of un-ionized drug (permeability) may also play a role in absorption. The ph of the vehicle has a strong influence on drug ionization o A higher unbound fraction of drug is also correlated with drug clearance from viable skin to the muscle o Another important component of topical drug efficacy is the vehicle. The composition of the vehicle (cream, gel or ointment), ph, lipid
6 Musculoskeletal Pain 4 characteristics and drug solubility in the vehicle, all influence the amount and depth of absorption of a drug into the skin and underlying tissues. Summary/Conclusions At present, there is no evidence regarding the efficacy/effectiveness, or potential side effects, of compounds consisting of gabapentin, ketamine, lidocaine and tramadol, of any concentration, in treating pain. At present, there is some evidence regarding the efficacy/effectiveness of topical tramadol in treating short term acute pain in children. At present, the science on topical drug delivery still requires further development, which may affect the current efficacy/effectiveness and safety of the drugs involved. References 1. Anonymous. Background. Paediatric. Anaesthesia. 22 (SUPPL. 1) (pp 1-79), Date of Publication: July Baron, R. Neuropathic pain: A clinical perspective. Handbook. of Experimental Pharmacology. 194 (pp 3-30), Date of Publication: Beecham Emma; Candy Bridget; Howard Richard; McCulloch Renee; Laddie, J. o.; Rees Henrietta; Vickerstaff Victoria; BluebondLangner Myra, and Jones Louise. Pharmacological interventions for pain in children and adolescents with life-limiting conditions. Cochrane. 2016; (4). 4. Centre for Reviews and Dissemination. A systematic review of pharmacologic treatments of pain after spinal cord injury. Database. 2015; (2). 5. De Leon-Casasola, O. New developments in the treatment algorithm for peripheral neuropathic pain. Pain. Medicine. 12 (SUPPL. 3) (pp S100-S108), Date of Publication: July Fallon M.T.; Colvin, L., and Rowbotham D.J. Neuropathic pain in cancer. British. Journal of Anaesthesia. 111 (1) (pp ), Date of Publication: July Gilron, I. and Coderre T.J. Emerging drugs in neuropathic pain. Expert. Opinion on Emerging Drugs. 12 (1) (pp ), Date of Publication: March Gilron, I.; Jensen T.S., and Dickenson A.H. Combination pharmacotherapy for management of chronic pain: From bench to bedside. The. Lancet Neurology. 12 (11) (pp ), Date of Publication: November Gilron, I.; Watson C.P.N.; Cahill C.M., and Moulin D.E. Neuropathic pain: A practical guide for the clinician. CMAJ. 175 (3) (pp ), Date of Publication: 01 Aug Hagen E.M. and Rekand, T. Management of Neuropathic Pain Associated with Spinal Cord Injury. Pain. and Therapy. 4 (1) (pp 51-65), Date of Publication: 22 Jun Hempenstall, K.; Nurmikko T.J.; Johnson R.W.; A'Hern R.P., and Rice A.S.C. Analgesic
7 Musculoskeletal Pain 5 therapy in postherpetic neuralgia: A quantitative systematic review. PLoS. Medicine. 2 (7) (pp ), Date of Publication: Hocking, G. and Cousins, M. Postherpetic neuralgia an update on management. Medicine. Today. 3 (11) (pp 16-26), Date of Publication: 01 Nov Johnson R.W. and Whitton T.L. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert. Opinion on Pharmacotherapy. 5 (3) (pp ), Date of Publication: March Judkins, D. and Goree, J. Multimodal approach to the treatment of CRPS. Regional. Anesthesia and Pain Medicine. Conference: 14th Annual Pain Medicine Meeting of the American Society of Regional Anesthesia and Pain Medicine, ASRA Miami, FL United States. Conference Start: Conference End: Conference Publication: (var.pagings). 41 (2) (no pagination), Date of Publication: March-April Kanazi G.E.; Johnson R.W., and Dworkin R.H. Treatment of postherpetic neuralgia: An update. Drugs. 59 (5) (pp ), Date of Publication: Kern K.-U. and Weiser, T. Topical ambroxol for the treatment of neuropathic pain: An initial clinical observation. English version. Schmerz. 29 (pp 89-96), Date of Publication: 01 Dec Mao, J.; Gold M.S., and Backonja, M. Combination drug therapy for chronic pain: A call for more clinical studies. Journal. of Pain. 12 (2) (pp ), Date of Publication: February Martinez, V. and Lanteri-Minet, M. Current pharmacological treatment, guidelines and prospects. [French]. Douleur. et Analgesie. 23 (2) (pp 93-98), Date of Publication: June Murphy E.J. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesthesia. and Intensive Care. 33 (3) (pp ), Date of Publication: June Napenas J.J. and Zakrzewska J.M. Diagnosis and management of trigeminal neuropathic pains. Pain. Management. 1 (4) (pp ), Date of Publication: July Niv, D. and Maltsman-Tseikhin, A. Postherpetic neuralgia: The never-ending challenge. Pain. Practice. 5 (4) (pp ), Date of Publication: December Paster, Z. and Morris C.M. Treatment of the localized pain of postherpetic neuralgia. Postgraduate. Medicine. 122 (1) (pp ), Date of Publication: January Scheinfeld, N. Topical treatments of skin pain: A general review with a focus on hidradenitis suppurativa with topical agents. Dermatology. Online Journal. 20 (7) (no pagination), Date of Publication: Vranken J.H. Elucidation of pathophysiology and treatment of neuropathic pain. Central. Nervous System Agents in Medicinal Chemistry. 12 (4) (pp ), Date of Publication: Akbay, B. K.; Yildizbas, S.; Guclu, E.; Yilmaz, S.; Iskender, A., and Ozturk, O. Analgesic efficacy of topical tramadol in the control of postoperative pain in children after tonsillectomy. Journal. of Anesthesia. 24(5):705-8, 2010 Oct. 26. Cuvas Apan, O.; Ozer, M. A.; Takir, S.; Apan, A., and Sengul, D. Effect of topical administration of tramadol on corneal wound healing in rats. International. Ophthalmology. 36(5):675-80, 2016 Oct.
8 Musculoskeletal Pain Gonul, O.; Satilmis, T.; Ciftci, A.; Sipahi, A.; Garip, H., and Goker, K. Comparison of the Effects of Topical Ketamine and Tramadol on Postoperative Pain After Mandibular Molar Extraction. Journal. of Oral & Maxillofacial Surgery. 73(11):2103-7, 2015 Nov. 28. Kayacan, N.; Karsli, B.; Ozbilim, G.; Bigat, Z.; Erman, M., and Karpuzoglu, G. Intravesical analgesia for ambulatory urologic procedures: A histopathological study. Ambulatory. Surgery. 10 (4) (pp ), Date of Publication: May Malik, S.; Wadhwani, J.; Zafar, S., and Aftab, S. Analgesic efficacy of topical tramadol in the control of postoperative pain in children after tonsillectomy. Anaesthesia. Pain and Intensive Care. Conference: 11th International Anaesthesia, Pain and Intensive Care Conference, APICON 11. Bhurban Pakistan. Conference Start: Conference End: Conference Publication: (var.pagings). 15 (2) (pp 158), Date of Publication: July-September Malik, S. Wadhwani J, Zafar S, Aftab S. Analgesic efficacy of topical tramadol in the control of postoperative pain in children after tonsillectomy. Anaesthesia. Pain and Intensive Care. Vol.15 (2), pp.158, Tekelioglu, U. Y.; Apuhan, T.; Akkaya, A.; Demirhan, A.; Yildiz, I.; Simsek, T.; Gok, U., and Kocoglu, H. Comparison of topical tramadol and ketamine in pain treatment after tonsillectomy. Paediatric. Anaesthesia. 23(6): , 2013 Jun. 32. Walls AP, Johjson S, Nguyen M et al. (2014). Compounding is Confounding Workers Compensation. Downloaded from in March Sommer C, Cruccu G, Topical Treatment of Peripheral Neuropathic Pain: Applying the Evidence, Journal of Pain and Symptom Management (2017), doi: /j.jpainsymman Lee CM and Maibach HI. Deep Percutaneous Penetration into Muscles and Joints. J Pharm Sci 2006;95: Jepps OG, Dancik Y, Anissimov YG and Roberts MS. Modeling the human skin barrier - Towards a better understanding of dermal absorption. Advanced Drug Delivery Reviews 2013;65: Higaki K, Asai M, Suyama T et al. Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer. International Journal of Pharmaceutics. Green DM, Jones AC and Brain KR. Content variability of active drug substance in compounded oral 3,4-diaminopyridine products. Journal of Clinical Pharmacy and Therapeutics. 2012;37: Sasich LD and Sukkari SR. Unknown Risks of Pharmacy-Compounded Drugs. The Journal of the American Osteopathic Association. February 2008;108(2):86.
9 Musculoskeletal Pain 7 Appendix 1 WorkSafeBC - Evidence-Based Practice Group Levels of Evidence (adapted from 1,2,3,4) Evidence from at least 1 properly randomized controlled trial (RCT) or systematic review of RCTs. Evidence from well-designed controlled trials without randomization or systematic reviews of observational studies. Evidence from well-designed cohort or case-control analytic studies, preferably from more than 1 centre or research group. Evidence from comparisons between times or places with or without the intervention. Dramatic results in uncontrolled Opinions of respected authorities, based on clinical experience, descriptive studies or reports of expert committees. References 1. Canadian Task Force on the Periodic Health Examination: The periodic health examination. CMAJ. 1979;121: Houston TP, Elster AB, Davis RM et al. The US Preventive Services Task Force Guide to Clinical Preventive Services, Second Edition. AMA Council on Scientific Affairs. American Journal of Preventive Medicine. May 1998;14(4): Scottish Intercollegiate Guidelines Network (2001). SIGN 50: a guideline developers' handbook. SIGN. Edinburgh. 4. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ. Aug 5, 2003;169(3):
Use of a Weighted Blanket as Treatment for Post-Traumatic Stress Disorder (PTSD), Anxiety, or Sleep Disorder
Evidence-Based Practice Group Answers to Clinical Questions Use of a Weighted Blanket as Treatment for Post-Traumatic Stress Disorder (PTSD), Anxiety, or Sleep Disorder A Rapid Systematic Review By WorkSafeBC
More informationElectric Muscle Stimulation (EMS) as Treatment for Chronic (Wrist) Pain
Evidence-Based Practice Group Answers to Clinical Questions Electric Muscle Stimulation (EMS) as Treatment for Chronic (Wrist) Pain A Rapid Systematic Review By WorkSafeBC Evidence-Based Practice Group
More informationEvidence-Based Practice Group Answers to Clinical Questions
Evidence-Based Practice Group Answers to Clinical Questions Is There Any Evidence On The Causal Association Between Transfemoral Amputation And The Development Of Contra-Lateral Hip Osteoarthritis? A Rapid
More informationIntranasal Ketamine With or Without Intranasal Oxytocin as Treatment for Complex Regional Pain Syndrome (CRPS) and/or Chronic Non-cancer Pain (CNCP)
Evidence-Based Practice Group Answers to Clinical Questions Intranasal Ketamine With or Without Intranasal Oxytocin as Treatment for Complex Regional Pain Syndrome (CRPS) and/or Chronic Non-cancer Pain
More informationDiagnosis and Treatment of Postherpetic Neuralgia
J KMA Special Issue Diagnosis and Treatment of Postherpetic Neuralgia Myung Ha Yoon, MD Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School E mail : mhyoon@jnu.ac.kr
More informationIF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?
NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this
More informationClinical Policy Title: Intravenous lidocaine infusion for neuropathic pain
Clinical Policy Title: Intravenous lidocaine infusion for neuropathic pain Clinical Policy Number: 03.03.08 Effective Date: June 1, 2014 Initial Review Date: January 19, 2014 Most Recent Review Date: January
More information7 th November % of patients had lidocaine plasters prescribed for the licensed indication of post herpatic neuralgia
Directorate of Integrated Care Health and Social Care Board 12-22 Linenhall Street Belfast BT2 8BS Tel : 028 90553782 Fax : 028 90553622 Web Site: www.hscboard.hscni.net 7 th November 2013 Dear colleague
More informationTITLE: Patient-Controlled Analgesia for Acute Injury Transfers: A Review of the Clinical Effectiveness, Safety, and Guidelines
TITLE: Patient-Controlled Analgesia for Acute Injury Transfers: A Review of the Clinical Effectiveness, Safety, and Guidelines DATE: 11 August 2014 CONTEXT AND POLICY ISSUES Patient-controlled analgesia
More information1. Developed: June Revised: November 2017; September 2015; December 2013; January 2012; December 2011; April 2010; August 2006.
Texas Vendor Drug Program Drug Use Criteria: Gabapentin Publication History 1. Developed: June 2006 2. Revised: November 2017; September 2015; December 2013; January 2012; December 2011; April 2010; August
More informationLiterature Scan: Topical Analgesics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More information5.9. Rehabilitation to Improve Central Pain
5.9. Rehabilitation to Improve Central Pain Evidence Tables and References Canadian Best Practice Recommendations for Stroke Care 2011-2013 Update Last Updated: June 25 th, 2013 Contents Search Strategy...
More informationGRALISE (gabapentin) oral tablet
GRALISE (gabapentin) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationGABAPENTIN BNF Gabapentin is a chemical analogue of γ-aminobutyric acid (GABA) but does not act
GABAPENTIN BNF 4.8.1 Class: Anti-epileptic. Indications: Adjunctive treatment for partial seizures with or without secondary generalisation; 1,2 neuropathic pain of any cause. 3 12 Pharmacology Gabapentin
More informationTUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Neuropathic Pain
1. Medical Condition Neuropathic pain is defined as pain that results from a lesion or disease in the somatosensory system. Neuropathic pain is frequently difficult to treat, and commonly interferes with
More informationCOMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT
JUNE 2012 COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING WWW.CPSRXS. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Acute Pain 2 Neuropathic
More informationNORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT
NOVEMBER 2011 NORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING N ORLANDA VENUEP HARMACY. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Sciatic Pain
More informationTITLE: Gabapentin for HIV-associated Neuropathic Pain: A Review of the Clinical Effectiveness
TITLE: Gabapentin for HIV-associated Neuropathic Pain: A Review of the Clinical Effectiveness DATE: 22 January 2016 CONTEXT AND POLICY ISSUES Neuropathic pain can be severe and debilitating and results
More informationTreatment of Neuropathic Pain: The Role of Unique Opioid Agents
Treatment of Neuropathic Pain: The Role of Unique Opioid Agents Agents that work against central nervous system receptors may be the key to successful pain management in patients with nerve damage or injury.
More informationCOMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT
JANUARY 2012 COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING WWW.CPSRXS. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Osteoarthritis Pain
More informationTITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness
TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness DATE: 08 October 2009 CONTEXT AND POLICY ISSUES: Poly-drug abuse is
More informationDrug Use Evaluation: Newer Antiepileptic Drugs Executive Summary
Drug Use Research & Management Program Oregon State University, 3303 SW Bond Av CH12C, Portland, Oregon 97239 4501 Phone 503 494 9954 Fax 503 494 1082 Drug Use Evaluation: Newer Antiepileptic Drugs Executive
More informationTITLE: Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness
TITLE: Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness DATE: 27 August 2014 CONTEXT AND POLICY ISSUES Mental illness, including major depressive episode,
More informationWhat s Practical in the Daily Practice of Evidence-Based Medicine?
What s Practical in the Daily Practice of Evidence-Based Medicine? Steven R. Craig, MD, FACP 2013-2014 Organization & Objectives of Presentation Review on-line EBM resources (Emphasis on Hardin Electronic
More informationOpioid Prescribing for Acute Pain. Care for People 15 Years of Age and Older
Opioid Prescribing for Acute Pain Care for People 15 Years of Age and Older Summary This quality standard provides guidance on the appropriate prescribing, monitoring, and tapering of opioids to treat
More informationAdvice following an Independent Review Panel (IRP)
Scottish Medicines Consortium Advice following an Independent Review Panel (IRP) Pregabalin 25, 50, 75, 100, 150, 200 and 300mg capsules (Lyrica ) Pfizer No. 157/05 7 July 2006 The Scottish Medicines Consortium
More informationNORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT
DECENBER 2011 NORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING N ORLANDA VENUEP HARMACY. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Trigeminal
More informationGuidelines on the Safe Practice of Acute Pain Management
Page 1 of 7 Guidelines on the Safe Practice of Acute Pain Version Effective Date 1 1 MAY 1994 (Reviewed Feb 2002) 2 1 DEC 2014 Document No. HKCA P11 v2 Prepared by College Guidelines Committee Endorsed
More informationTITLE: Physical Therapy Treatments for Chronic Non-Cancer Pain: A Review of Guidelines. DATE: 10 November 2016 CONTEXT AND POLICY ISSUES
TITLE: Physical Therapy Treatments for Chronic Non-Cancer Pain: A Review of Guidelines DATE: 10 November 2016 CONTEXT AND POLICY ISSUES Chronic pain is one of the most common reasons for seeking medical
More informationABS Acai Sterols EFA Natural + Sustainable + Protectant. Tomorrow s Vision Today!
ABS Acai Sterols EFA Natural + Sustainable + Protectant Tomorrow s Vision Today! ABS Acai Sterols EFA Technical Information: Product Code: 10414 INCI Name: Euterpe Oleracea Sterols INCI Status: Conforms
More informationA review of Neuropathic Pain: From Guidelines to Clinical Practice
Pain Ther (2017) 6 (Suppl 1):S35 S42 DOI 10.1007/s40122-017-0087-0 REVIEW A review of Neuropathic Pain: From Guidelines to Clinical Practice Giorgio Cruccu. Andrea Truini Received: October 12, 2017 Ó The
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
More informationNeurontin drug class. Search
Neurontin drug class Search Neurontin is an anti-epileptic drug, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some. Is Gabapentin
More informationCity of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS)
City of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS) Vancouver Vancouver Fire Rescue Services Opioid Crisis Background Crisis Overview April
More informationRecommendations on Screening for High Blood Pressure in Canadian Adults 2012
Recommendations on Screening for High Blood Pressure in Canadian Adults 2012 Canadian Task Force on Preventive Health Care (CTFPHC) Putting Prevention into Practice Canadian Task Force on Preventive Health
More informationIntroduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
Introduction to 1 Pharmacokinetics University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 2 Learning objectives Understand compartment models and how they effects
More informationCANADIAN STROKE BEST PRACTICE RECOMMENDATIONS. Stroke Rehabilitation Evidence Tables Rehabilitation to Improve Central Pain
CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS Rehabilitation to Improve Central Pain Hebert, D, Teasell, R (Writing Group Chairs) on Behalf of the STROKE REHABILITATION Writing Group 2015 December 2015
More informationDigital RIC. Rhode Island College. Linda M. Green Rhode Island College
Rhode Island College Digital Commons @ RIC Master's Theses, Dissertations, Graduate Research and Major Papers Overview Master's Theses, Dissertations, Graduate Research and Major Papers 1-1-2013 The Relationship
More informationPain and Itch Assessment and Management for the Burns Patient (Adults) Type: Clinical guideline Register No: Status: Public
Pain and Itch Assessment and Management for the Burns Patient (Adults) Type: Clinical guideline Register No: 15025 Status: Public Developed in response to: Best Practice Contributes to CQC Regulation 9,11
More informationInnovative Management of Pain Through Compounding. Shawn Needham R.Ph.
Innovative Management of Pain Through Compounding Shawn Needham R.Ph. Disclosure Shawn Needham is a compounding pharmacist and does have interest in a compounding pharmacy Compounded pharmaceuticals are
More informationNational Institute for Health and Care Excellence. Neuropathic pain - pharmacological management Guideline consultation. Stakeholder Comments
National Institute for Health and Care Excellence Neuropathic pain - pharmacological management Guideline consultation Stakeholder Comments Please enter the name of your registered stakeholder organisation
More informationDeveloping Evidence-Based Best Practices for the Prescribing and Use of Proton Pump Inhibitors in Canada
Developing Evidence-Based Best Practices for the Prescribing and Use of Proton Pump Inhibitors in Canada Presented by: Sumeet R. Singh, COMPUS April 4, 2006 Background COMPUS Objective: To identify and
More informationGenital Trauma *************************** Ureteral Trauma
Genital Trauma September 26>, Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily 1 exp genital injury/ (4099) 2 (penis/ or testis/ or vagina/) and (blunt trauma/ or penetrating
More information2018 Learning Outcomes
I. Pain Physiology and Anatomy (20%) A. Describe the basic anatomy of the nervous system. B. Describe the physiological mechanisms of neuronal function (eg- action potentials). C. Review the nociceptive
More informationBrief Research Reports Health Care Expenditure Burden of Persisting Herpes Zoster Pain
Blackwell Publishing IncMalden, USAPMEPain Medicine1526-2375American Academy of Pain Medicine? 200693348353 Original ArticleBurden of Persisting Herpes Zoster PainDworkin et al. PAIN MEDICINE Volume 9
More informationVWA expectations for the delivery of osteopathic services to injured workers
Information on Osteopathy Who can provide osteopathic services to injured workers? VWA Victoria (VWA), will only pay for osteopathic services by healthcare professionals who are: registered by VWA to provide
More informationPharmacologic and Nonpharmacologic Interventions for Pain
PUTTING EVIDENCE INTO PRACTICE: IMPROVING ONCOLOGY PATIENT OUTCOMES Pharmacologic and Nonpharmacologic Interventions for Pain Introduction A variety of treatments such as chemotherapy, radiation therapy,
More information16 year old with Disabling Chest Wall Pain after Thoracoscopic Talc Pleurodesis for Treatment of Recurrent Spontaneous Pneumothoraces
16 year old with Disabling Chest Wall Pain after Thoracoscopic Talc Pleurodesis for Treatment of Recurrent Spontaneous Pneumothoraces Moderators: Kendra Grim, MD, Robert T. Wilder, MD, PhD Institution:
More informationCurrent evidence in acute pain management. Jeremy Cashman
Current evidence in acute pain management Jeremy Cashman Optimal analgesia Best possible pain relief Lowest incidence of side effects Optimal analgesia Best possible pain relief Lowest incidence of side
More informationMed Wreck to Med Rec How medication reconciliation can (should) change your practice!
Med Wreck to Med Rec How medication reconciliation can (should) change your practice! Dan Martinusen BSc(Pharm),ACPR, PharmD Chair, BCPRA Pharmacy & Formulary Committee Marianna Leung B Sc(Pharm), ACPR,
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 3019-9 Program Step Therapy Medication Lyrica capsules, Lyrica Solution, Lyrica CR tablets* (pregabalin) P&T Approval Date 1/08,
More informationPrescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks
Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks Patient Health and Safety Guidelines Prescription Medications Policy Update / April 2017 In connection
More informationPfizer Independent Grants for Learning & Change Track 2- Annual Meetings: Submission Deadlines, Areas of Interest & Educational Goals
In order to submit a request for general meeting support through Track 2- Annual Meetings the answer to the following questions must be Yes : Does the activity align with Pfizer s areas of interest? (listed
More informationWhat do we want for pain medications?
New Trends in Pain Pharmacotherapy Dr. Chi Wai Cheung MBBS(HK), FHKCA, FHKAM(Anaesthesiology), Dip Pain Mgt(HKCA) Clinical Assistant Professor Department of Anaesthesiology The University of Hong Kong
More informationTitle: Parenteral Iron Therapy for Anemia: A Clinical and Cost-Effectiveness Review
Title: Parenteral Iron Therapy for Anemia: A Clinical and Cost-Effectiveness Review Date: 14 February 2008 Context and policy issues: Anemia is a complication of chronic diseases and commonly occurs in
More informationPOST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS
POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS November 9, 2018 Aimee LaMere, CNP Molly McNaughton, CNP Leslie Weide, MSW, LICSW, ACM Disclosures: Conflict of interest statement: We certify that,
More informationAccelerating the Development of Enhanced Pain Treatments March 25, Bermuda
Accelerating the Development of Enhanced Pain Treatments March 25, 2011 - Bermuda Accelerating the Development of Enhanced Pain Treatments March 25, 2011 - Bermuda Proof-of-concept trials Ian Gilron, MD,
More information01/07/2018 ISCHAEMIC PAIN IN NON-RECONSTRUCTABLE CRITICAL LIMB ISCHAEMIA PRESENTATION OUTLINE
ISCHAEMIC PAIN IN NON-RECONSTRUCTABLE CRITICAL LIMB ISCHAEMIA Dr. Áine Ní Laoire The Oxford Advanced Pain & Symptom Management Course Nottingham 27 th June 2018 PRESENTATION OUTLINE A Typical Case Background
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS Frequently Asked Questions: Table of Contents What clinical clues help distinguish between nociceptive and neuropathic pain? Can I combine treatments? Why should the treatment
More informationREFERENCES for PLATELET RICH PLASMA (PRP)
REFERENCES for PLATELET RICH PLASMA (PRP) Daif ET. Autologous blood injection as a new treatment modality for chronic recurrent temporomandibular joint dislocation. Oral Surg Oral Med Oral Pathol Oral
More information8/6/18. Definitions. Disclosures. Technician Objectives. Pharmacist Objectives. Chronic Pain. Non-Opioid Alternatives for Chronic Pain Management
Disclosures Non-Opioid Alternatives for Chronic Management Nicholas Cox, PharmD, BCACP Clinical Pharmacist, Intensive Outpatient Clinic, University of Utah Health Pharmacist, Population Health, University
More informationIs Topical Clonazepam More Effective Than Oral Clonazepam in Treatment of Burning Mouth Syndrome (BMS)?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2014 Is Topical Clonazepam More Effective
More informationTITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines
TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines DATE: 08 May 2014 CONTEXT AND POLICY ISSUES Electroconvulsive therapy (ECT) is a treatment that
More informationTopical Preparations
Topical Preparations One of the functions of the skin is to protect the internal body components against the external environment and thus to control the passage of chemicals into and out of the body.
More information1. exp Narcotics/ or exp Opiate Alkaloids/ or exp Fentanyl/ or exp meperidine/ or exp Morphine Derivatives/ or exp Methadone/
Appendix 1A-Search strategy Appendix 1A-Search strategy Search Date: 2014-11-26 Database searched: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to Present+Ovid MEDLINE(R)
More informationMedication trends shaping workers compensation. A 2018 mid-year review of the prevailing industry influences impacting pharmacy outcomes
Medication trends shaping workers compensation A 2018 mid-year review of the prevailing industry influences impacting pharmacy outcomes OPTUM WORKERS COMPENSATION DATA SET Analysis of our data, the industry
More informationSetting The setting was primary and secondary care. The economic study was carried out in Canada.
Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective Tarride J E, Gordon A, Vera-Llonch
More informationCapsaicin cutaneous patch
New Medicines Profile August 2010 Issue. 10/03 cutaneous patch Concise evaluated information to support the managed entry of new medicines in the NHS Summary cutaneous patch (Qutenza ) is licensed for
More informationTITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines
TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines DATE: 17 January 2014 CONTEXT AND POLICY ISSUES Obstructive sleep apnea (OSA) is a common
More informationManagement of Pain related to Spinal Cord Lesion
Management of Pain related to Spinal Cord Lesion A Neurologist s Perspective Vincent Mok, MD Associate Professor Division of Neurology Department of Medicine and Therapeutics The Chinese University of
More informationLidoderm (Lidocaine) Patch
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationLeeds West CCG Paediatric asthma project. January 2015-January 2017
Leeds West CCG Paediatric asthma project. January 2015-January 2017 Aims to raise asthma awareness improve care reduce emergency attendances and unplanned admissions to secondary care for children with
More informationPOST-OP MULTIMODAL PAIN MANAGEMENT. Maripat Welz-Bosna Reading Hospital Medical Center Department of Medicine Hospitalist Services/Pain Management
POST-OP MULTIMODAL PAIN MANAGEMENT Maripat Welz-Bosna Reading Hospital Medical Center Department of Medicine Hospitalist Services/Pain Management Objectives Understand the basic neurobiology of the pain
More informationLearning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16
Acute Pain in the Chronic Pain Patient for Ambulatory Surgery Danielle Ludwin, MD Associate Professor of Anesthesiology Division of Regional and Orthopedic Anesthesia Columbia University Medical Center
More informationCHRONIC PAIN & OPIOID PRESCRIBING GUIDELINES
CHRONIC PAIN & OPIOID PRESCRIBING GUIDELINES The following guidelines have been reviewed and endorsed by the New Brunswick Medical Society July 2004 Chronic pain can be due to cancer or noncancer conditions.
More informationConcepts for the talk. Poisoning by Topical Medications The Toxicology of Transdermal Drug Delivery. Early patches. The transdermal patch
Concepts for the talk Poisoning by Topical Medications The Toxicology of Transdermal Drug Delivery Lewis Nelson, M.D. New York University School of Medicine New York City Poison Control Center Understand
More informationAn observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population
Hall et al. BMC Family Practice 2013, 14:28 RESEARCH ARTICLE Open Access An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population Gillian C Hall
More informationGUIDELINES AND AUDIT IMPLEMENTATION NETWORK
GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management
More informationGG&C Chronic Non Malignant Pain Opioid Prescribing Guideline
GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline Background Persistent pain is common, affecting around five million people in the UK. For many sufferers, pain can be frustrating and disabling,
More informationDATE: 17 July 2012 CONTEXT AND POLICY ISSUES
TITLE: Sterile Pre-filled Saline Syringes for Acute Care Patients: A Review of Clinical Evidence, Cost-effectiveness, Evidence-based Guidelines, and Safety DATE: 17 July 2012 CONTEXT AND POLICY ISSUES
More informationOvid. A Spectrum of Resources to Support Evidence-Based Medical Research. Susan Lamprey Sturchio, MLIS. June 14, 2015
Ovid Susan Lamprey Sturchio, MLIS A Spectrum of Resources to Support Evidence-Based Medical Research Evidence is Where Global Healthcare is Headed By 2020, 90% of clinical decisions will be supported by
More informationCOUNTY GOVERNMENT OF NYERI
COUNTY GOVERNMENT OF NYERI COUNTY PUBLIC SERVICE BOARD NCG/NCPSB/1 880 Date: 19 th May 2017 Ag. County Secretary, Chief Officer, Department of Health. P.O. BOX 90 10100 Telephone 061 2030700 RE: INTERNAL
More informationEvidence-based Clinical Practice Guidelines on Management of Pain in Older People Aza Abdulla, Margaret Bone, Nicola Adams, Alison M.
Evidence-based Clinical Practice Guidelines on Management of Pain in Older People Aza Abdulla, Margaret Bone, Nicola Adams, Alison M. Elliott, Derek Jones, Roger Knaggs, Denis Martin, Elizabeth L. Sampson,
More informationCanadian Journal of Anesthesia/Journal canadien d anesthésie. Evidence-Based Clinical Updates (EBCU s) in Anesthesia
Canadian Journal of Anesthesia/Journal canadien d anesthésie Evidence-Based Clinical Updates (EBCU s) in Anesthesia INSTRUCTIONS FOR AUTHORS The Canadian Journal of Anesthesia considers for publication
More informationPerformance Measure Name: TOB-3 Tobacco Use Treatment Provided or Offered at Discharge TOB-3a Tobacco Use Treatment at Discharge
Measure Information Form Collected For: The Joint Commission Only CMS Informational Only Measure Set: Tobacco Treatment (TOB) Set Measure ID #: Last Updated: New Measure Version 4.0 Performance Measure
More informationMedication Agreements Promoting awareness, dialogue and level-set expectations
Medication Agreements Promoting awareness, dialogue and level-set expectations A young man had his leg amputated following a work-related injury. His pain doctor, by all accounts, was trying to responsibly
More informationDuration of Action/Which Local Anesthetics to Use. Stephan Klessinger, Germany
Duration of Action/Which Local Anesthetics to Use Stephan Klessinger, Germany No Disclosures Potency Speed of Onset Duration of Action A Variety of Local Anesthetics Cocaine 1884 Problems: addiction not
More informationPharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration
Pharmaceutics I صيدالنيات 1 Unit 2 Route of Drug Administration 1 Routs of Drug administration The possible routes of drug entry into the body may be divided into two classes: Parenteral Rout Enteral Rout
More informationOriginal Article A comparison of analgesic effects between intradermal injection and epidural block of lidocaine for postherpetic neuralgia
Int J Clin Exp Med 2018;11(9):9694-9700 www.ijcem.com /ISSN:1940-5901/IJCEM0063502 Original Article A comparison of analgesic effects between intradermal injection and epidural block of lidocaine for postherpetic
More informationImproving Mental Health Care: A Case Study
Improving Mental Health Care: A Case Study Why Improve Mental Health Care? Because the prevalence and costs of mental health problems are increasing in America despite the high prescribing of psychotropic
More informationWashington, DC, November 9, 2009 Institute of Medicine
Holger Schünemann, MD, PhD Chair, Department of Clinical Epidemiology & Biostatistics Michael Gent Chair in Healthcare Research McMaster University, Hamilton, Canada Washington, DC, November 9, 2009 Institute
More informationNew Developments in the Treatment Algorithm for Peripheral Neuropathic Painpme_
Pain Medicine 2011; 12: S100 S108 Wiley Periodicals, Inc. New Developments in the Treatment Algorithm for Peripheral Neuropathic Painpme_1160 100..108 Oscar de Leon-Casasola, MD School of Medicine and
More informationHealth Technology Appraisal of Spinal Cord Stimulation for Chronic Pain of Neuropathic or Ischaemic Origin (HTA 07/08)
Health Technology Appraisal of Spinal Cord Stimulation for Chronic Pain of Neuropathic or Ischaemic Origin (HTA 07/08) This submission is being made on behalf of the Pain Relief Foundation (PRF) and the
More informationMedical Policy Manual. Topic: Peripheral Subcutaneous Field Stimulation Date of Origin: April Section: Surgery Last Reviewed Date: April 2014
Medical Policy Manual Topic: Peripheral Subcutaneous Field Stimulation Date of Origin: April 2013 Section: Surgery Last Reviewed Date: April 2014 Policy No: 188 Effective Date: July 1, 2014 IMPORTANT REMINDER
More informationImpact of asystematic review on subsequent clinical research
Impact of asystematic review on subsequent clinical research The case of the prevention of propofol injection pain Céline Habre 1,Martin R Tramèr 1,DanielM Pöpping 2, Nadia Elia 1,3 1 Division of Anaesthesiology,
More informationAcceptance onto Dialysis Guidelines
Guidelines John Kelly (Kogarah, New South Wales) Melissa Stanley (Melbourne, Victoria) David Harris (Westmead, New South Wales) Date written: December 2004 Final submission: June 2005 Predialysis education
More informationTITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety
TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety DATE: 1 April 2010 CONTEXT AND POLICY ISSUES: The prevalence of epilepsy ranges from 0.5% to 1%, 1,2 and
More informationNORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING FOR VETERINARY MEDICINE
OCTOBER 2011 PRESCRIPTION COMPOUNDING N ORLANDA VENUEP HARMACY. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Feline Analgesic Agent Feline Hypertension
More informationThe Cochrane Skin Group - Core Outcome Set Initiative to develop core outcome sets across the whole of dermatology
The Cochrane Skin Group - Core Outcome Set Initiative to develop core outcome sets across the whole of dermatology Jan Kottner On behalf of the CSG-COUSIN 1 Background I Non-comparable outcome measures
More informationBest practices in pain management
Best practices in pain management Ian Power Anaesthesia, Critical Care and Pain Medicine www.anaes.med.ed.ac.uk/ The Royal Infirmary of Edinburgh, Little France How effective is postoperative pain therapy?
More information